Health & Life Sciences

Health & Life Sciences

Reach patients, providers, and policymakers with credible health communications

Health communications require scientific accuracy, regulatory compliance, and genuine empathy. We help healthtech companies, biotech firms, and healthcare organisations build awareness and trust with the audiences that matter.

Accuracy and sensitivity most agencies cannot deliver

Health and life sciences communications demand a level of accuracy and sensitivity that most agencies are not equipped to deliver. Claims about health products and services are regulated by the TGA and AHPRA in Australia, and the consequences of non-compliant communications range from regulatory enforcement to genuine harm. Third Hemisphere understands these boundaries because we work within them every day, helping healthtech companies, biotech firms, medical device manufacturers, and digital health platforms communicate their innovations to the audiences that matter: clinicians, patients, regulators, investors, and payers.

Expertise across the entire health-innovation lifecycle

Our health communications expertise spans the entire lifecycle of health innovation. We have supported healthtech startups launching their first products to market, helping them build credibility with early adopter clinicians and generate the media coverage that attracts growth-stage investors. We have worked with biotech companies communicating clinical trial milestones and regulatory approvals, translating complex scientific data into clear, accurate narratives that build investor confidence without overstating outcomes. And we have helped established health organisations communicate service innovations and policy positions to government and media.

Bridging scientific rigour and compelling storytelling

What sets Third Hemisphere apart in health communications is our ability to bridge the gap between scientific rigour and compelling storytelling. Our team includes communications professionals with backgrounds in health journalism and science communication who understand both the regulatory framework and the editorial standards that govern health media coverage. Every health communication we produce is reviewed for accuracy, compliance, and strategic effectiveness before it reaches any audience.

Three engagements, one discipline

Three engagements show how that plays out. For ANDHealth, the peak body connecting digital health innovators with the health system, we built the communications that positioned the organisation as a credible authority on health technology adoption. For Neoretina Eyecare Institute, we built patient trust and market visibility for a specialist ophthalmology provider in a competitive market. For the Stoma Industry Association, we supported advocacy and awareness communications for patients living with a stoma and the clinicians who treat them. Each engagement required the same discipline: get the clinical claim right first, then make it accessible.

Industry challenges

  • Regulatory Compliance in Health Communications TGA and AHPRA regulations strictly govern what can be communicated about health products, treatments, and services. Non-compliant communications can result in enforcement action, product de-listing, and reputational damage that is difficult to recover from.
  • Translating Clinical Evidence into Accessible Narratives Health innovations are built on clinical evidence, but investors, media, and patients need narratives that are accurate without being impenetrable. Finding the balance between scientific precision and accessibility is one of the hardest communications challenges in any sector.
  • Building Trust Across Clinicians, Patients, and Regulators Health companies must simultaneously earn trust from clinicians who demand evidence, patients who need empathy, regulators who require compliance, and investors who want growth narratives. Each audience has fundamentally different information needs.
  • Handling Health Media Sensitivity Health journalists apply higher editorial standards than most other beats. Speculative claims, unverified data, or sensationalised narratives will damage credibility with the journalists who matter most in health media.

What we deliver

Third Hemisphere brings science communication expertise, regulatory awareness, and strategic media relationships to help health and life sciences organisations communicate effectively with every audience they depend on. We work alongside regulatory, clinical, and legal teams to ensure every communication is accurate, compliant, and strategically sound. Our health communications team includes professionals with backgrounds in science journalism and health media who understand TGA requirements, AHPRA guidelines, and the editorial standards that health journalists apply when evaluating stories. We develop communications strategies that reach clinicians, patients, regulators, investors, and payers with appropriately tailored messaging for each audience, ensuring scientific accuracy without sacrificing accessibility or emotional resonance.

We measure every health engagement against the outcome the brief was set for, whether that is clinician adoption, patient enquiries, investor confidence, or policy engagement, and we review every piece of content against TGA and AHPRA requirements before anyone outside the company sees it. Where a health client's category is now researched through AI engines, we extend the same CRISP diagnostic we use across the agency, scoring how ChatGPT, Claude, Copilot, Gemini, and Perplexity represent the company across 50 real buyer and clinician questions.

  • TGA and AHPRA compliant media relations targeting health, business, and technology journalists
  • Clinical milestone communications including trial results, regulatory approvals, and product launches
  • Executive thought leadership positioning for health CEOs and clinician-founders at medical conferences and in health media
  • Investor communications for healthtech capital raises and pre-IPO campaigns
  • Patient-facing communications that balance scientific accuracy with empathy and accessibility
  • Policy and government communications for health organisations engaging with policymakers

Does Third Hemisphere have experience with health regulatory environments?

Yes. Third Hemisphere understands TGA regulations, AHPRA guidelines and the specific requirements for communicating about health products and services in Australia. We work closely with regulatory and legal teams to ensure all communications are compliant while still being compelling.

Can Third Hemisphere help with patient-facing communications?

Yes. Third Hemisphere develops communications strategies that reach patients, caregivers, healthcare providers and policymakers, each with appropriately tailored messaging that balances scientific accuracy with empathy and accessibility.

What types of health organisations does Third Hemisphere work with?

Third Hemisphere works with healthtech companies, biotech firms, medical device manufacturers, digital health platforms, pharmaceutical companies, health insurers and healthcare providers. We also support health-focused non-profits and government health initiatives across Australia and the Asia-Pacific region.

How does PR support a healthtech company's growth?

PR builds credibility with the audiences that matter most in healthcare: clinicians, patients, regulators, investors and payers. Third Hemisphere develops media strategies that position healthtech innovations in respected medical, business and technology publications, building the trust required for adoption and investment.

Can Third Hemisphere help communicate clinical trial results?

Yes. Third Hemisphere helps biotech and pharmaceutical companies communicate clinical milestones, trial results and regulatory approvals to media, investors and the public. We translate complex scientific data into clear, accurate narratives that build confidence without overstating outcomes.

Does Third Hemisphere understand the difference between B2B and B2C health communications?

Yes. B2B health communications target clinicians, hospital administrators and health system decision-makers with evidence-based messaging. B2C communications reach patients and consumers with accessible, empathetic content. Third Hemisphere develops tailored strategies for both audiences, often as part of an integrated campaign.

Does Third Hemisphere work with peak bodies and health advocacy organisations?

Yes. Third Hemisphere has supported ANDHealth, the peak body connecting digital health innovators with the health system, and the Stoma Industry Association, building advocacy and awareness communications for patients and the clinicians who treat them.

Has Third Hemisphere worked with specialist medical providers?

Yes. Third Hemisphere built patient trust and market visibility for Neoretina Eyecare Institute, a specialist ophthalmology provider, developing communications that balanced clinical accuracy with the empathy patient-facing content requires.

Can Third Hemisphere support a healthtech company's capital raise?

Yes. Third Hemisphere develops investor communications for healthtech capital raises and pre-IPO campaigns, translating clinical evidence and commercial traction into narratives that satisfy both TGA-aware compliance review and investor scrutiny, coordinated with the company's regulatory and legal advisers throughout the raise.

Related case studies

Related insights